Isupetasys이수페타시스
007660 · KOSPI · ₩007660 · 이수페타시스
Analyst target price
Average target
₩180,000
Upside
+102.2%
Range ₩180,000 – ₩180,000 · 1 broker (latest target within 6 months)
Buy 1
Consensus target vs price, 2 years
Earnings estimates
Brokers' earnings estimates and how they've been revised, with Pro.
Unlock with ProBroker reports
| Date | Broker | Report | Rating | Target | Change | Upside | Since publish | Read |
|---|---|---|---|---|---|---|---|---|
| Oct 8 | Yuanta Securities Korea | 3Q26 Pre: Stacking growth drivers | Buy | ₩180,000 | New | +102.2% | −29.1% | Read ↗ |
Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.
AI summary of public information
An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.
Isupetasys is highly profitable on trailing numbers, but its share price has fallen sharply over the past month and trades well below its 52-week high.
The printed circuit board maker reported trailing twelve-month revenue of ₩1.31T and operating income of ₩259B to H1 2026, with a 19.7% operating margin. Its shares closed at ₩83,500 on 2026-10-26, down 29.8% over one month but only 10.8% over one year. Free cash flow over the same period was negative at ₩-112B, and borrowings of ₩283B exceed cash of ₩144B.
What stands out
- Revenue grew 30% in 2025 to ₩1.09T, and operating margin rose to 18.8% from 12.2% in 2024.
- Trailing free cash flow is negative at ₩-112B, so reported profits are not yet turning into cash in this period.
- The DCF fair value model gives a base of ₩31,438, bear ₩20,313 and bull ₩48,557, all well below the current price; the model's basis and inputs are not detailed in the data.
- Foreign ownership edged up to 17.4% from 17.1% over 60 days, while institutions sold about ₩143B over the last 20 days and foreign investors bought about ₩125B.
- The only recent headline in the data says profitability improved on expansion of high-spec products; no company guidance is included.
What to watch
- The next half-year or annual results and whether free cash flow turns positive as borrowings stay high.
- Continued insider shareholding and 5%+ holding filings, which have been frequent in recent weeks.
- Valuation risk: the P/E of 30.5 compares with peers ranging from 13.1 to 82.9, and the share price is about 49% below its 52-week high of ₩164,400.
Data as of Oct 26, 2026 · written yesterday
This is not financial advice.
Also known as: Isupetasys / 이수페타시스 / 007660 / KRX:007660
Source: KRX statistical information